Chuk
"Sorry, I can't remember where I read or heard the ML was anticipated by around the end of trial mining but it was public. Perhaps someone else remembers."
No problem. I hope someone else chimes in regarding this as end of trial mining versus end of calendar year can have some very big differences with regards to cash flow.
**If** it is December/ish than by the time stage 2 sales are booked there may be very little cash without a raising of some sort. Conversely, if you are correct and it is within the next couple of months than there should be no issue.
Like I said, I can only go by the CFO statement this morning ("hoping by end of calander year")which is why I raised the question to begin with.
I like what I am seeing here and I'm looking to take a personal position, however I want to be clear about **possible** CR before I purchase (for obvious reasons).
"I see no reason why that would take more than 1 year -if that.
"Bit confused here as I didn't mention any cash flow estimates in relation to stage 3."
I realise that but you assumed stage 2 continues for 3 years and I was just pointing out my assumption is an earlier move to stage 3 therefore giving different cash flow estimate. "
Ok, point taken here. You are making some logical assumptions which I cannot argue either way so time will tell in that respect.
As I see it regardless of the timing. Once they get into stage 2 then the future should be bright assuming no unforseen issues.
It's simply a question of available funds between end of trial mining and stage 2 commencement.
- Forums
- ASX - By Stock
- PRX
- posing a few questions re. abm
PRX
prodigy gold nl
Add to My Watchlist
0.00%
!
0.3¢

posing a few questions re. abm, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.525M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 215000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 0.003 |
7 | 19892257 | 0.002 |
50 | 213871310 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 215000 | 2 |
0.003 | 76210765 | 34 |
0.004 | 12798333 | 8 |
0.005 | 1935720 | 3 |
0.006 | 50000 | 1 |
Last trade - 09.54am 04/07/2025 (20 minute delay) ? |
Featured News
PRX (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online